iRadimed Corporation (United States) is listed on the Nasdaq and has a market capitalization of $1.14 billion, with shareholders equity totaling $101.75 million.
The company employs approximately 110 people and operates in the Health sector, within the Medical Supplies and Equipment industry.
Over the past 12 months, iRadimed Corporation reported $86.34 million in revenue, generating net income of $23.06 million.
Key financial metrics include a P/E ratio of 49.39, a price-to-book (P/B) ratio of 11.19, and a trailing twelve-month dividend yield of 1.43%.
The company trades under the ticker IRMD.